Skip to content

Efficacy and safety of eszopiclone in the treatment of insomnia complicated with nocturnal awakenings associated with urination.

Efficacy and safety of eszopiclone in the treatment of insomnia complicated with nocturnal awakenings associated with urination. - Effect of eszopiclone in insomnia with nocturia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013808
Enrollment
60
Registered
2014-06-01
Start date
2015-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia complicated with nocturnal awakenings associated with urination.

Interventions

eszopiclone(1-3mg/day) no therapy

Sponsors

Department of medicine,School of Medicine, Nihon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with insomnia complicated with nocturnal awakenings associated with urination.

Exclusion criteria

Exclusion criteria: (1)hyper sensitive patients to eszopiclone or zopiclone (2)myasthenia gravis (3)acute narrow-angle glaucoma (4)pulmonale,emphysema and during stage of acute asthma and cerebral vascular disturbance several respiratory disability (5)bladder cancer and prostate cancer (6)Patients who received any prior therapeutic medication for OAB(over active bladder) less than one month before entry (7)Patients who received any prior therapeutic medication for BPH(being prostatic hypertrophy) less than six months before entry

Design outcomes

Primary

MeasureTime frame
(1)QOL for insomnia patients of sleep disorder (2)Frequency of vonding at night

Secondary

MeasureTime frame
(1)Changes in Pittsburg Sleep Quality Index (2)Volume of vonding at night (3)The time from awakening to getting to sleep again (4)The time from getting to sleep to awakening first at night (5)A questionnaire of comprehensive evaluation

Countries

Japan

Contacts

Public ContactHodota Emiko

Department of medicine,School of Medicine, Nihon University Division of Urology

hodota.emiko@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026